Efficacy of S‐1 after pemetrexed in patients with non‐small cell lung cancer: A retrospective multi‐institutional analysis-Reference-Cited by-同舟云学术

Efficacy of S‐1 after pemetrexed in patients with non‐small cell lung cancer: A retrospective multi‐institutional analysis

Published:2021-07-13 Issue:17 Volume:12 Page:2300-2306
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Takemoto Shinnosuke¹^ORCID,Akagi Kazumasa²,Ono Sawana³,Tomono Hiromi⁴,Honda Noritaka¹,Suyama Takayuki¹,Umeyama Yasuhiro¹,Dotsu Yosuke¹,Taniguchi Hirokazu⁵^ORCID,Ogawara Daiki⁶,Senju Hiroaki⁷,Gyotoku Hiroshi¹^ORCID,Sugasaki Nanae⁸,Yamaguchi Hiroyuki¹^ORCID,Nakatomi Katsumi⁹,Fukuda Minoru¹⁰^ORCID,Mukae Hiroshi¹

Affiliation:

1. Department of Respiratory Medicine Nagasaki University Graduate, School of Biomedical Sciences Nagasaki Japan

2. Department of Respiratory Medicine Japanese Red Cross Nagasaki Genbaku Isahaya Hospital Nagasaki Japan

3. Department of Respiratory Medicine Japanese Red Cross Nagasaki Genbaku Hospital Nagasaki Japan

4. Department of Respiratory Medicine National Hospital Organization Nagasaki Medical Center Nagasaki Japan

5. Molecular Pharmacology Program and Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA

6. Department of Respiratory Medicine Fukuoka Wajiro Hospital Fukuoka Japan

7. Department of Respiratory Medicine Sasebo City General Hospital Nagasaki Japan

8. Department of Respiratory Medicine Nagasaki Prefecture Shimabara Hospital Nagasaki Japan

9. Department of Respiratory Medicine National Hospital Organization Ureshino Medical Center Saga Japan

10. Department of Clinical oncology Center Nagasaki University Hospital Nagasaki Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14055

Reference20 articles.

1. Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

2. Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)

3. Genetic factors influencing Pyrimidine-antagonist chemotherapy

4. Significance of thymidylate synthase expression for resistance to pemetrexed in pulmonary adenocarcinoma

5. Thymidylate Synthase Expression Determines Pemetrexed Targets and Resistance Development in Tumour Cells